Literature DB >> 9331640

Clinical epidemiology of rheumatic fever and rheumatic heart disease in tropical Australia.

J R Carapetis1, B J Currie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331640     DOI: 10.1007/978-1-4899-1825-3_56

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  Vaccination against rheumatic heart disease: a review of current research strategies and challenges.

Authors:  Manisha Pandey; Michael R Batzloff; Michael F Good
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.

Authors:  Hae-Sun Park; P Patrick Cleary
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever.

Authors:  J R Carapetis; B J Currie
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

4.  Prevalence of rheumatic heart disease in a public school of Belo Horizonte.

Authors:  Lavinia Pimentel Miranda; Paulo Augusto Moreira Camargos; Rosália Morais Torres; Zilda Maria Alves Meira
Journal:  Arq Bras Cardiol       Date:  2014-08       Impact factor: 2.000

5.  Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia.

Authors:  Danielle B Clucas; Kylie S Carville; Christine Connors; Bart J Currie; Jonathan R Carapetis; Ross M Andrews
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

6.  Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma.

Authors:  Manisha Pandey; Victoria Ozberk; Ainslie Calcutt; Emma Langshaw; Jessica Powell; Tania Rivera-Hernandez; Mei-Fong Ho; Zachary Philips; Michael R Batzloff; Michael F Good
Journal:  PLoS Pathog       Date:  2016-12-27       Impact factor: 6.823

7.  Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.

Authors:  Philip M Giffard; Steven Y C Tong; Deborah C Holt; Anna P Ralph; Bart J Currie
Journal:  PLoS Negl Trop Dis       Date:  2019-07-03

8.  Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians.

Authors:  Samantha M Colquhoun; John R Condon; Andrew C Steer; Shu Q Li; Steven Guthridge; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2015-07-28       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.